Explore
Trendline
Nanalysis Scientific Corp to Host First Quarter 2026 Conference Call for Investors
Nanalysis Scientific Corp to Host First Quarter 2026 Conference Call for Investors
Read More
Trendline
REGENXBIO Faces Setbacks with Duchenne Gene Therapy Amid Safety Concerns
REGENXBIO Faces Setbacks with Duchenne Gene Therapy Amid Safety Concerns
Read More
Trendline
Longeveron Reports Q1 Financial Results and Strategic Updates
Longeveron Reports Q1 Financial Results and Strategic Updates
Read More
Trendline
Imunon, Inc. Reports Increased Net Loss in Q1 2026 Amid Clinical Advancements
Imunon, Inc. Reports Increased Net Loss in Q1 2026 Amid Clinical Advancements
Read More
Trendline
Curis Reports Q1 2026 Financial Results and Advances Cancer Drug Trials
Curis Reports Q1 2026 Financial Results and Advances Cancer Drug Trials
Read More
Trendline
Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026
Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026
Read More
Trendline
Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call
Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call
Read More
Trendline
Crescita Reports Increased Revenue and Gross Profit in Q1 2026
Crescita Reports Increased Revenue and Gross Profit in Q1 2026
Read More
Trendline
Anteris Technologies Reports Q1 2026 Financial Results with Revenue Decline
Anteris Technologies Reports Q1 2026 Financial Results with Revenue Decline
Read More
Trendline
Anteris Technologies Reports Q1 2026 Financial Results with Increased Net Loss
Anteris Technologies Reports Q1 2026 Financial Results with Increased Net Loss
Read More
Trendline
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Advances
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Advances
Read More
Trendline
AN2 Therapeutics Reports Q1 2026 Financial Results and Pipeline Updates
AN2 Therapeutics Reports Q1 2026 Financial Results and Pipeline Updates
Read More
